Page last updated: 2024-08-24

atorvastatin and Cardiotoxicity

atorvastatin has been researched along with Cardiotoxicity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Abdel-Qadir, H; Amir, E; Billia, F; Brezden-Masley, C; Chan, J; Connelly, KA; Hanneman, K; Houbois, C; Huang, F; Kei, T; Marwick, TH; Maze, D; Pezo, RC; Power, C; Prica, A; Runeckles, K; Saha, S; Shalmon, T; Thavendiranathan, P; Thorpe, KE; Wintersperger, BJ1
Patrono, C; Pedicino, D1
Alenabi, A; Hallaj-Salahipour, M; Khoramjouy, M; Malekinejad, H; Malekinejad, M; Masoumi Verki, M1
Ahmed, LA; Attalla, DM; Khattab, MM; Zaki, HF1
Chen, W; Gao, G; Ge, L; Jiang, S; Sui, S; Zhai, C; Zhang, S1
Chen, J; Gao, L; Gao, X; He, X; Qi, Z; Zhang, K; Zhou, Y1

Trials

1 trial(s) available for atorvastatin and Cardiotoxicity

ArticleYear
Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
    European heart journal. Cardiovascular pharmacotherapy, 2023, 09-20, Volume: 9, Issue:6

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Atorvastatin; Biomarkers; Breast Neoplasms; Cardiotoxicity; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Stroke Volume; Ventricular Function, Left

2023

Other Studies

5 other study(ies) available for atorvastatin and Cardiotoxicity

ArticleYear
Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?
    European heart journal, 2023, 11-14, Volume: 44, Issue:43

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Atorvastatin; Cardiotoxicity; Drug-Related Side Effects and Adverse Reactions; Humans; Neoplasms

2023
Cardioprotective Effects of Atorvastatin Are Mediated Through PPARγ in Paraquat-Exposed Rats.
    Journal of cardiovascular pharmacology, 2019, Volume: 74, Issue:5

    Topics: Animals; Antioxidants; Atorvastatin; Cardiotoxicity; Creatine Kinase, MB Form; Cyclooxygenase 2; Disease Models, Animal; Heart Diseases; Lipid Peroxidation; Male; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Paraquat; Peroxidase; PPAR gamma; Rats, Wistar; Signal Transduction; Sulfhydryl Compounds

2019
Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 104

    Topics: Animals; Antioxidants; Atorvastatin; Biomarkers; Cardiotonic Agents; Cardiotoxicity; Heart; Inflammation; Isoproterenol; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Wistar

2018
Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
    Journal of cardiovascular pharmacology, 2019, Volume: 73, Issue:4

    Topics: Animals; Apoptosis; Atorvastatin; Cardiotoxicity; Caspase 3; Disease Models, Animal; Doxorubicin; Fibrosis; Heart Failure; Heart Ventricles; HSP70 Heat-Shock Proteins; Male; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2019
Atorvastatin Ameliorates Radiation-Induced Cardiac Fibrosis in Rats.
    Radiation research, 2015, Volume: 184, Issue:6

    Topics: Animals; Atorvastatin; Cardiotoxicity; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Immunologic Factors; Male; Radiation Dosage; Radiation-Protective Agents; Radiation, Ionizing; Rats; Rats, Sprague-Dawley; Treatment Outcome

2015
chemdatabank.com